DM
GILD icon

Deerfield Management’s Gilead Sciences GILD Stock Holding History

Deerfield Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-200,000
Closed -$19.6M – 129
2015
Q1 		$19.6M Hold
200,000
– – 0.64% 41
2014
Q4 		$18.9M Buy
+200,000
New +$20.7M 0.68% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Deerfield Management's GILD Position: Q3 2024 in Review

Deerfield Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 1,491,000 shares — an estimated $102M sold.

Deerfield Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $102M in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Deerfield Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Deerfield Management sold 1,491,000 Gilead Sciences shares in Q3 2024, an estimated $102M.
  • Deerfield Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • Deerfield Management's Gilead Sciences position peaked at $102M in Q2 2024.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.